Finance

Lists
LUNG:NASDAQ
Pulmonx Corp
1,91 US$
0,00%
(0,00) 1D
30 სექ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LUNG...
Mkt. cap
82,03 მლნ.
Avg. vol.
324,05 ათ.
Volume
5,00
52-wk high
2,89 US$
52-wk low
1,13 US$
EPS
-1,16 US$
Beta
0,34
Shares outstanding
42,95 მლნ.
No. of employees
296
Mkt. cap
82,03 მლნ.
Avg. vol.
324,05 ათ.
Volume
5,00
52-wk high
2,89 US$
52-wk low
1,13 US$
EPS
-1,16 US$
Beta
0,34
Shares outstanding
42,95 მლნ.
No. of employees
296
News stories
From web sources and news partners
About Pulmonx Corp
CEO-
Employees296
Founded1995
HeadquartersRedwood City, კალიფორნია, ამერიკის შეერთებული შტატები
SectorMedical device
Websitepulmonx.com
Analyst ratings
Based on 4 analysts giving stock ratings to LUNG in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LUNG in the last 3 months.
Highest
Current 1,91 US$
5,00 US$ (+161,78%)
Average
3,50 US$ (+83,25%)
Lowest
2,50 US$ (+30,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Maintained
5,00 US$
+161,8%
08/11/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
2,50 US$
+30,9%
07/30/2026
Frank Takkinen
Lake Street
Buy
Reiterated
4,00 US$
+109,4%
07/30/2026
Jason Bednar
Piper Sandler
Hold
Maintained
2,50 US$
+30,9%
07/30/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
5,00 US$
+161,8%
04/30/2026
Last report
29 ივლ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,24 US$ / -0,28 US$
+14,29%beat
Revenue / Est. (USD)
22,76 მლნ. / 22,50 მლნ.
+1,14%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
21,50 მლნ.
22,60 მლნ.
20,59 მლნ.
22,76 მლნ.
Cost of goods sold
5,45 მლნ.
5,06 მლნ.
4,54 მლნ.
5,01 მლნ.
Cost of revenue
5,45 მლნ.
5,06 მლნ.
4,54 მლნ.
5,01 მლნ.
Research and development expenses
4,85 მლნ.
4,58 მლნ.
4,90 მლნ.
5,03 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,60 მლნ.
22,86 მლნ.
24,10 მლნ.
21,76 მლნ.
Operating expense
30,44 მლნ.
27,44 მლნ.
29,00 მლნ.
26,80 მლნ.
Total operating expenses
35,90 მლნ.
32,50 მლნ.
33,54 მლნ.
31,81 მლნ.
Operating income
-14,39 მლნ.
-9,90 მლნ.
-12,96 მლნ.
-9,06 მლნ.
Other non operating income
-42,00 ათ.
81,00 ათ.
277,00 ათ.
99,00 ათ.
EBT including unusual items
-13,83 მლნ.
-10,24 მლნ.
-13,50 მლნ.
-9,95 მლნ.
EBT excluding unusual items
-13,83 მლნ.
-10,24 მლნ.
-13,50 მლნ.
-9,95 მლნ.
Income tax expense
128,00 ათ.
186,00 ათ.
149,00 ათ.
133,00 ათ.
Effective tax rate
-0,93%
-1,82%
-1,10%
-1,34%
Other operating expenses
-
-
-
-
Net income
-13,96 მლნ.
-10,42 მლნ.
-13,65 მლნ.
-10,08 მლნ.
Net profit margin
-64,91%
-46,13%
-66,33%
-44,30%
Earnings per share
-0,34
-0,25
-0,33
-0,24
Interest and investment income
611,00 ათ.
453,00 ათ.
350,00 ათ.
329,00 ათ.
Interest expense
-805,00 ათ.
-770,00 ათ.
-976,00 ათ.
-1,22 მლნ.
Net interest expenses
-194,00 ათ.
-317,00 ათ.
-626,00 ათ.
-889,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,25 მლნ.
-9,57 მლნ.
-12,84 მლნ.
-8,84 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები